List of Tables
Table 1. Global Vulvar and Vaginal Atrophy Therapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Vulvar and Vaginal Atrophy Therapy Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Vulvar and Vaginal Atrophy Therapy Market Competitive Situation by Manufacturers in 2024
Table 4. Global Vulvar and Vaginal Atrophy Therapy Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Vulvar and Vaginal Atrophy Therapy Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Vulvar and Vaginal Atrophy Therapy Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Vulvar and Vaginal Atrophy Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Vulvar and Vaginal Atrophy Therapy, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Vulvar and Vaginal Atrophy Therapy, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vulvar and Vaginal Atrophy Therapy, Product Type & Application
Table 12. Global Key Manufacturers of Vulvar and Vaginal Atrophy Therapy, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vulvar and Vaginal Atrophy Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vulvar and Vaginal Atrophy Therapy as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vulvar and Vaginal Atrophy Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Vulvar and Vaginal Atrophy Therapy Sales by Region (2020-2025) & (K Units)
Table 18. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Region (2020-2025)
Table 19. Global Vulvar and Vaginal Atrophy Therapy Sales by Region (2026-2031) & (K Units)
Table 20. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Region (2026-2031)
Table 21. Global Vulvar and Vaginal Atrophy Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Region (2020-2025)
Table 23. Global Vulvar and Vaginal Atrophy Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Region (2026-2031)
Table 25. North America Vulvar and Vaginal Atrophy Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Vulvar and Vaginal Atrophy Therapy Sales by Country (2020-2025) & (K Units)
Table 27. North America Vulvar and Vaginal Atrophy Therapy Sales by Country (2026-2031) & (K Units)
Table 28. North America Vulvar and Vaginal Atrophy Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Vulvar and Vaginal Atrophy Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Vulvar and Vaginal Atrophy Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Vulvar and Vaginal Atrophy Therapy Sales by Country (2020-2025) & (K Units)
Table 32. Europe Vulvar and Vaginal Atrophy Therapy Sales by Country (2026-2031) & (K Units)
Table 33. Europe Vulvar and Vaginal Atrophy Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Vulvar and Vaginal Atrophy Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Vulvar and Vaginal Atrophy Therapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Vulvar and Vaginal Atrophy Therapy Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Vulvar and Vaginal Atrophy Therapy Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Vulvar and Vaginal Atrophy Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Vulvar and Vaginal Atrophy Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Vulvar and Vaginal Atrophy Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Vulvar and Vaginal Atrophy Therapy Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Vulvar and Vaginal Atrophy Therapy Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Vulvar and Vaginal Atrophy Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Vulvar and Vaginal Atrophy Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Vulvar and Vaginal Atrophy Therapy Sales (K Units) by Type (2020-2025)
Table 51. Global Vulvar and Vaginal Atrophy Therapy Sales (K Units) by Type (2026-2031)
Table 52. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Type (2020-2025)
Table 53. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Type (2026-2031)
Table 54. Global Vulvar and Vaginal Atrophy Therapy Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Vulvar and Vaginal Atrophy Therapy Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Type (2020-2025)
Table 57. Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Type (2026-2031)
Table 58. Global Vulvar and Vaginal Atrophy Therapy Price (USD/Unit) by Type (2020-2025)
Table 59. Global Vulvar and Vaginal Atrophy Therapy Price (USD/Unit) by Type (2026-2031)
Table 60. Global Vulvar and Vaginal Atrophy Therapy Sales (K Units) by Application (2020-2025)
Table 61. Global Vulvar and Vaginal Atrophy Therapy Sales (K Units) by Application (2026-2031)
Table 62. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Application (2020-2025)
Table 63. Global Vulvar and Vaginal Atrophy Therapy Sales Market Share by Application (2026-2031)
Table 64. Global Vulvar and Vaginal Atrophy Therapy Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Vulvar and Vaginal Atrophy Therapy Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Application (2020-2025)
Table 67. Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Application (2026-2031)
Table 68. Global Vulvar and Vaginal Atrophy Therapy Price (USD/Unit) by Application (2020-2025)
Table 69. Global Vulvar and Vaginal Atrophy Therapy Price (USD/Unit) by Application (2026-2031)
Table 70. Almirall Company Information
Table 71. Almirall Description and Business Overview
Table 72. Almirall Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Almirall Vulvar and Vaginal Atrophy Therapy Product
Table 74. Almirall Recent Developments/Updates
Table 75. VenusConcept Company Information
Table 76. VenusConcept Description and Business Overview
Table 77. VenusConcept Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. VenusConcept Vulvar and Vaginal Atrophy Therapy Product
Table 79. VenusConcept Recent Developments/Updates
Table 80. Alma Lasers Company Information
Table 81. Alma Lasers Description and Business Overview
Table 82. Alma Lasers Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Alma Lasers Vulvar and Vaginal Atrophy Therapy Product
Table 84. Alma Lasers Recent Developments/Updates
Table 85. ThermiGen LLC Company Information
Table 86. ThermiGen LLC Description and Business Overview
Table 87. ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Product
Table 89. ThermiGen LLC Recent Developments/Updates
Table 90. Lutronic Company Information
Table 91. Lutronic Description and Business Overview
Table 92. Lutronic Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Lutronic Vulvar and Vaginal Atrophy Therapy Product
Table 94. Lutronic Recent Developments/Updates
Table 95. BTL Group of Companies Company Information
Table 96. BTL Group of Companies Description and Business Overview
Table 97. BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Product
Table 99. BTL Group of Companies Recent Developments/Updates
Table 100. Viveve Company Information
Table 101. Viveve Description and Business Overview
Table 102. Viveve Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Viveve Vulvar and Vaginal Atrophy Therapy Product
Table 104. Viveve Recent Developments/Updates
Table 105. Fotona Company Information
Table 106. Fotona Description and Business Overview
Table 107. Fotona Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Fotona Vulvar and Vaginal Atrophy Therapy Product
Table 109. Fotona Recent Developments/Updates
Table 110. Hologic Company Information
Table 111. Hologic Description and Business Overview
Table 112. Hologic Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Hologic Vulvar and Vaginal Atrophy Therapy Product
Table 114. Hologic Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Vulvar and Vaginal Atrophy Therapy Distributors List
Table 118. Vulvar and Vaginal Atrophy Therapy Customers List
Table 119. Vulvar and Vaginal Atrophy Therapy Market Trends
Table 120. Vulvar and Vaginal Atrophy Therapy Market Drivers
Table 121. Vulvar and Vaginal Atrophy Therapy Market Challenges
Table 122. Vulvar and Vaginal Atrophy Therapy Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Vulvar and Vaginal Atrophy Therapy
Figure 2. Global Vulvar and Vaginal Atrophy Therapy Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Vulvar and Vaginal Atrophy Therapy Market Share by Type: 2024 & 2031
Figure 4. Vulvar Atrophy Therapy Product Picture
Figure 5. Vaginal Atrophy Therapy Product Picture
Figure 6. Global Vulvar and Vaginal Atrophy Therapy Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Vulvar and Vaginal Atrophy Therapy Market Share by Application: 2024 & 2031
Figure 8. Hospitals
Figure 9. Ambulatory Surgical Centers
Figure 10. Specialty Clinics
Figure 11. Others
Figure 12. Global Vulvar and Vaginal Atrophy Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Vulvar and Vaginal Atrophy Therapy Market Size (2020-2031) & (US$ Million)
Figure 14. Global Vulvar and Vaginal Atrophy Therapy Sales (2020-2031) & (K Units)
Figure 15. Global Vulvar and Vaginal Atrophy Therapy Average Price (USD/Unit) & (2020-2031)
Figure 16. Vulvar and Vaginal Atrophy Therapy Report Years Considered
Figure 17. Vulvar and Vaginal Atrophy Therapy Sales Share by Manufacturers in 2024
Figure 18. Global Vulvar and Vaginal Atrophy Therapy Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Vulvar and Vaginal Atrophy Therapy Players: Market Share by Revenue in Vulvar and Vaginal Atrophy Therapy in 2024
Figure 20. Vulvar and Vaginal Atrophy Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Vulvar and Vaginal Atrophy Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Vulvar and Vaginal Atrophy Therapy Sales Market Share by Country (2020-2031)
Figure 23. North America Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Country (2020-2031)
Figure 24. United States Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Vulvar and Vaginal Atrophy Therapy Sales Market Share by Country (2020-2031)
Figure 27. Europe Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Country (2020-2031)
Figure 28. Germany Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Vulvar and Vaginal Atrophy Therapy Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Region (2020-2031)
Figure 35. China Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Vulvar and Vaginal Atrophy Therapy Sales Market Share by Country (2020-2031)
Figure 45. Latin America Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Vulvar and Vaginal Atrophy Therapy Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Vulvar and Vaginal Atrophy Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Vulvar and Vaginal Atrophy Therapy by Type (2020-2031)
Figure 55. Global Revenue Market Share of Vulvar and Vaginal Atrophy Therapy by Type (2020-2031)
Figure 56. Global Vulvar and Vaginal Atrophy Therapy Price (USD/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Vulvar and Vaginal Atrophy Therapy by Application (2020-2031)
Figure 58. Global Revenue Market Share of Vulvar and Vaginal Atrophy Therapy by Application (2020-2031)
Figure 59. Global Vulvar and Vaginal Atrophy Therapy Price (USD/Unit) by Application (2020-2031)
Figure 60. Vulvar and Vaginal Atrophy Therapy Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
